NPS RADAR provides health professionals with timely, independent evidence-based information on new drugs and medical tests and changes to listings on the Pharmaceutical Benefits Scheme.

NPS RADAR is print-published 3 times a year, in line with major updates to the Schedule of Pharmaceutical Benefits, so it is available around the time when new medicines can be prescribed or dispensed.

Our free NPS RADAR email alerts keep subscribers up to date with new drugs and medical tests as each new issue of NPS RADAR is released.

Latest issue

Editorial: RADAR 'up-GRADE'

This issue introduces a further enhancement to the evidence appraisal in the form of the GRADE systematic evaluation of the quality of evidence, endorsed by many national and international organisations as a systematic and transparent framework for communicating the quality of evidence and strength of recommendations in healthcare.

Ivermectin (Stromectol) for typical and crusted scabies

Ivermectin (Stromectol) was recently given TGA approval and is now PBS listed for the treatment of typical and crusted scabies. Where does ivermectin fit in treatment?

Ferric carboxymaltose (Ferinject) for iron-deficiency anaemia

Ferric carboxymaltose (Ferinject) is a PBS-listed parenteral iron preparation with characteristics that allow larger single doses to be administered over a shorter infusion period compared with existing IV iron preparations.

Tapentadol sustained release (Palexia SR) for chronic, severe disabling pain

Tapentadol SR is a centrally acting opioid analgesic used for treating chronic, severe disabling pain not responding to non-opioid analgesics.

Brief item: Aclidinium (Bretaris Genuair) for chronic obstructive pulmonary disease

Aclidinium bromide is a long-acting anticholinergic (or long-acting muscarinic-receptor antagonist) with efficacy and safety similar to those of tiotropium and glycopyrronium, and now PBS listed for maintenance treatment of chronic obstructive pulmonary disease.

Brief item: More than just evidence summaries — rating the quality of evidence with GRADE

NPS MedicineWise is proud to join other evidence-based organisations, including the WHO and Cochrane Collaboration, in adopting the Grades of recommendation, assessment, development, and evaluation (GRADE) framework for our various publications, starting with our 'flagship' NPS RADAR.

Download issue